Ligand id: 6971

Name: oprelvekin

1. Berl T, Schwertschlag U. (2000)
Preclinical pharmacologic basis for clinical use of rhIL-11 as an effective platelet-support agent.
Oncology (Williston Park, N.Y.), 14 (9 Suppl 8): 12-20. [PMID:11033834]
2. Jung Y, Ahn H, Kim DS, Hwang YR, Ho SH, Kim JM, Kim S, Ma S, Kim S. (2011)
Improvement of biological and pharmacokinetic features of human interleukin-11 by site-directed mutagenesis.
Biochem. Biophys. Res. Commun., 405 (3): 399-404. [PMID:21238428]
3. Wilde MI, Faulds D. (1998)
Oprelvekin: a review of its pharmacology and therapeutic potential in chemotherapy-induced thrombocytopenia.
BioDrugs, 10 (2): 159-71. [PMID:18020592]